Chiral Analysis of 2-Hydroxyglutarate in IDH-mut Glioma Tissue using the Kinetic Method
Analytical Chemistry · 10.11.2026 · 98 (44) · 30370-30377
DOI: 10.1021/acs.analchem.6c03172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 10.10.2026. Verfasst von Mahdiyeh Shahi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Purdue University, West Lafayette, Indiana47907, United States. Hauptthemen laut MEDLINE: Glutarates, Isocitrate Dehydrogenase, Glioma, Brain Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: NCI NIH HHS, Waters Corporation, Purdue University Center for Cancer Research.
Abstract (Originalsprache)
In almost all biological systems, stereochemistry is an important aspect of the molecular structure. Aberrant molecular geometry can be a reflection of the disease state which is then manifested through effects on cellular metabolism. A well-known example occurs in isocitrate dehydrogenase (IDH)-mutant (mut) cancers, where the mutant IDH enzyme produces a unique chiral molecule, d-2-hydroxyglutarate (d-2HG). d-2HG accumulates in IDH-mut tumors and disrupts cellular pathways, including epigenetic regulation. Here, we apply the kinetic method to direct chiral analysis of 2HG in human glioma tissue. A trimeric cluster ion, [Ni(II)(Ac-l-Phe)2(l-2HG)−H]+, is formed and fragmented during tandem mass spectrometry (MS/MS). Cluster ions containing different 2HG geometry show distinctive fragment intensities. Calibration curves spanning from −100% to +100% enantiomeric excess (ee) were constructed, and the effects of potential interferences, including glutamate (Glu) and glutamine (Gln), were assessed. Using these data, we developed a chromatography-free method to determine the ee of 2HG in the glioma tissue. Chiral analysis of IDH-mut glioma tissue samples using the kinetic method was validated using LC−MS, with ee values agreeing within < 12%. Detection of predominantly d-2HG in tissue samples from (IDH)-mutant cancer is consistent with the neomorphic gain of function associated with the IDH mutation. This separation-free workflow enables rapid chiral analysis of 2HG in IDH-mut cancers and may provide complementary information to support intraoperative decision-making and precision medicine applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Purdue University, West Lafayette, Indiana47907, United States.
ORCID-Profile: Mahdiyeh Shahi, Jie Li, Robert Graham Cooks
Förderung
- NCI NIH HHS
- Waters Corporation
- Purdue University Center for Cancer Research
Zitieren
APA
Shahi, M., Li, J., & Cooks, R. G. (2026). Chiral Analysis of 2-Hydroxyglutarate in IDH-mut Glioma Tissue using the Kinetic Method. Analytical Chemistry, 98(44), 30370-30377. https://doi.org/10.1021/acs.analchem.6c03172
Vancouver
Shahi M, Li J, Cooks RG. Chiral Analysis of 2-Hydroxyglutarate in IDH-mut Glioma Tissue using the Kinetic Method. Analytical Chemistry. 2026;98(44):30370-30377. doi:10.1021/acs.analchem.6c03172
BibTeX
@article{Shahi2026,
author = {Shahi, Mahdiyeh and Li, Jie and Cooks, Robert Graham},
title = {Chiral Analysis of 2-Hydroxyglutarate in IDH-mut Glioma Tissue using the Kinetic Method},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {44},
pages = {30370--30377},
doi = {10.1021/acs.analchem.6c03172}
}
EUVIMED